Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

Brazil

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul

Irmandade Da Santa Casa De Misericórdia De Porto Alegre, Porto Alegre, Rio Grande do Sul

Hospital Alemão Oswaldo Cruz, São Paulo, São Paulo

Clínica de Pesquisa e Centro de Estudos em Oncologia Ginecológica e Mamária Ltda, São Paulo, São Paulo

Canada

Juravnski Cancer Centre, Hamitlon, Ontario

Ottawa Hospital Research Institute, Ottawa, Ontario

Toronto General Hospital, University Health Network, Toronto, Ontario

Russia

E.Meshalkin National medical research center of the Ministry of Health of the Russian Federation, Novosibirsk